ATE541856T1 - Stark verbrückte peptide aus der actinomadura namibiensis - Google Patents

Stark verbrückte peptide aus der actinomadura namibiensis

Info

Publication number
ATE541856T1
ATE541856T1 AT09728150T AT09728150T ATE541856T1 AT E541856 T1 ATE541856 T1 AT E541856T1 AT 09728150 T AT09728150 T AT 09728150T AT 09728150 T AT09728150 T AT 09728150T AT E541856 T1 ATE541856 T1 AT E541856T1
Authority
AT
Austria
Prior art keywords
bridged peptides
actinomadura namibiensis
strongly
strongly bridged
namibiensis
Prior art date
Application number
AT09728150T
Other languages
English (en)
Inventor
Mark Broenstrup
Hans Guehring
Holger Hoffmann
Joachim Wink
Roderich Suessmuth
Timo Schmiederer
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE541856T1 publication Critical patent/ATE541856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT09728150T 2008-04-02 2009-03-18 Stark verbrückte peptide aus der actinomadura namibiensis ATE541856T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08290324 2008-04-02
PCT/EP2009/001982 WO2009121483A1 (en) 2008-04-02 2009-03-18 Highly bridged peptides from actinomadura namibiensis

Publications (1)

Publication Number Publication Date
ATE541856T1 true ATE541856T1 (de) 2012-02-15

Family

ID=39730602

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09728150T ATE541856T1 (de) 2008-04-02 2009-03-18 Stark verbrückte peptide aus der actinomadura namibiensis

Country Status (16)

Country Link
US (1) US20110144001A1 (de)
EP (1) EP2271665B1 (de)
JP (1) JP5653900B2 (de)
KR (1) KR101612275B1 (de)
CN (1) CN102046652B (de)
AR (1) AR071125A1 (de)
AT (1) ATE541856T1 (de)
AU (1) AU2009231118B2 (de)
BR (1) BRPI0910985A2 (de)
CA (1) CA2720173A1 (de)
CL (1) CL2009000791A1 (de)
IL (1) IL208239A0 (de)
MX (1) MX2010010115A (de)
MY (1) MY159790A (de)
RU (1) RU2498995C2 (de)
WO (1) WO2009121483A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1908774A1 (de) * 2006-10-06 2008-04-09 sanofi-aventis Antibakterielle und antivirale Peptide aus Actinomadura namibiensis
DK2257301T3 (da) 2008-03-03 2014-04-28 Univ Miami Immunterapi baseret på allogene cancerceller.
KR20110017356A (ko) 2008-03-20 2011-02-21 유니버시티 오브 마이애미 열충격 단백질 ｇｐ96 백신접종 및 이를 사용하는 방법
EP2607374A1 (de) * 2011-12-21 2013-06-26 Sanofi Verfahren zur rekombinanten Herstellung von Labyrinthopeptinen und funktionalen Derivaten davon
WO2014009763A1 (en) * 2012-07-12 2014-01-16 Naicons S.C.A.R.L. Novel lantipeptide
WO2017085257A1 (en) 2015-11-18 2017-05-26 Helmholtz-Zentrum für Infektionsforschung GmbH Labyrinthopeptins as anti-viral agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2207636T3 (es) * 1994-09-12 2004-06-01 Aventis Pharma Deutschland Gmbh Mersacidina recombinante y un metodo para su produccion.
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
JP4664924B2 (ja) * 2003-12-02 2011-04-06 ウーツェーベー ファルマ ゲーエムベーハー 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用
CN100516218C (zh) * 2006-04-30 2009-07-22 中山大学 一种新的线纹芋螺毒素序列、制备方法及其应用
EP1908774A1 (de) * 2006-10-06 2008-04-09 sanofi-aventis Antibakterielle und antivirale Peptide aus Actinomadura namibiensis
EP2607374A1 (de) * 2011-12-21 2013-06-26 Sanofi Verfahren zur rekombinanten Herstellung von Labyrinthopeptinen und funktionalen Derivaten davon

Also Published As

Publication number Publication date
AU2009231118A1 (en) 2009-10-08
BRPI0910985A2 (pt) 2019-09-24
EP2271665A1 (de) 2011-01-12
CA2720173A1 (en) 2009-10-08
JP2011516048A (ja) 2011-05-26
EP2271665B1 (de) 2012-01-18
HK1155762A1 (en) 2012-05-25
KR101612275B1 (ko) 2016-04-14
MX2010010115A (es) 2010-09-30
AU2009231118B2 (en) 2013-06-27
IL208239A0 (en) 2010-12-30
RU2498995C2 (ru) 2013-11-20
US20110144001A1 (en) 2011-06-16
MY159790A (en) 2017-01-31
WO2009121483A1 (en) 2009-10-08
RU2010144778A (ru) 2012-05-10
JP5653900B2 (ja) 2015-01-14
AR071125A1 (es) 2010-05-26
CN102046652B (zh) 2014-11-05
CL2009000791A1 (es) 2009-10-09
KR20110014563A (ko) 2011-02-11
CN102046652A (zh) 2011-05-04

Similar Documents

Publication Publication Date Title
FR22C1054I2 (fr) Amides peptidiques synthetiques
EP2118122A4 (de) Neuartige antimikrobielle peptide
BRPI0907363A2 (pt) Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
BRPI0911743A2 (pt) "peptídeo"
EP2360172A4 (de) Bipodaler peptidbinder
EP2027271A4 (de) Rekombinante vektoren
EP2279202A4 (de) Multimere formen antimikrobieller peptide
GB0723712D0 (en) Peptides
BRPI1010661A2 (pt) peptídeo
BRPI0909119A2 (pt) vetores recombinantes do rinovírus
EP2513137A4 (de) Aus saposin-a gewonnene peptide und verwendungen davon
GB0920981D0 (en) Peptides
ATE541856T1 (de) Stark verbrückte peptide aus der actinomadura namibiensis
DK2207790T3 (da) Biologisk aktive C-terminalt argininholdige peptider
EP2285827A4 (de) Peptide und ihre verwendung
ATE547425T1 (de) Optimiertes dengue-virus-eintrittshemmendes peptid (dn81)
EP2123666A4 (de) Peptid
EP2280988A4 (de) Angiogenes peptid
GB0801513D0 (en) Peptides from factor VIII
EP2252310A4 (de) Heterozyklische peptid-ketoamide
EP2370100A4 (de) Peptidhilfsstoffe
GB0703945D0 (en) Peptide
FI20075483A0 (fi) Uusi peptidi
GB0920987D0 (en) Peptides
DK2081952T3 (da) Peptider